Novozymes A/S

Novozymes A/S FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Novozymes A/S (NSIS B.CO) as of Oct 10, 2026 is 215.86 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 69.31 % — a change of 211.43% (higher).

FCF Conversion

215.86 %

YoY

211.43%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Novozymes A/S is 2024 215.86 % . FCF Conversion Rate (FCF/EBITDA) of Novozymes A/S was 2023 69.31 % . It decreases by 211.43% higher compared to the previous year.

The Novozymes A/S FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
76.02 EUR
Jan 1, 2018
70.89 EUR
Jan 1, 2019
69.72 EUR
Jan 1, 2020
120.88 EUR
Jan 1, 2021
89.70 EUR
Jan 1, 2022
30.36 EUR
Jan 1, 2023
69.31 EUR
Jan 1, 2024
215.86 EUR
The Novozymes A/S FCF Conversion history
YEARFCF ConversionYoY
215.86 %+211.43%
69.31 %+128.31%
30.36 %-66.16%
89.70 %-25.80%
120.88 %+73.38%
69.72 %-1.65%
70.89 %-6.74%
76.02 %-11.64%
86.03 %+5.23%
81.76 %—
Access this data via the Eulerpool API

Novozymes A/S Stock analysis

What does Novozymes A/S do? Novozymes A/S is a leading company in the field of biocatalysis and microbial solutions. It was founded in Denmark in 1925 under the name Nordisk Insulinlaboratorium. In 2000, the company was renamed Novozymes A/S and became part of the globally operating Novo Group. Novozymes' business model is to optimize the use of biocatalysts, enzymes, and microorganisms to offer sustainable solutions for various industries. Biocatalysts are biological molecules that accelerate or enable chemical reactions. The company works closely with customers in agriculture, household, food and beverage, laundry and cleaning products, animal feed, bioenergy, and biopharmaceutical industries. Novozymes' offerings include various divisions. The largest is the enzymes division, which produces enzymes for various industries. Novozymes' enzymes are used in the food and beverage industry, pulp and paper industry, and bioenergy, among others. The microbial solutions division offers various microorganisms that can be used in the production of biogas, animal feed, or odor removal. Novozymes also has a bioagriculture division that develops solutions for sustainable agriculture. This includes disease- and pest-resistant bioseeds, as well as enhanced soil and plant care. The company also has a biopharmaceutical division that focuses on producing enzymes for disease treatment. An important goal of Novozymes is to promote sustainability and environmental protection. The company advocates for the use of renewable resources and energy-efficient processes. This is also reflected in their products, which contribute to optimizing agricultural processes and reducing greenhouse gas emissions, for example. One example of a Novozymes product is NovoGro, a biofertilizer for sustainable agriculture. NovoGro enhances nutrient uptake in plants and contributes to healthy soils. Another product is an enzyme blend called Novozyme 188, which is used in beer production to improve filtration. In summary, Novozymes A/S is a company specializing in biocatalysis and microbial solutions. The company works closely with customers from various industries to offer sustainable solutions and promote environmental protection. Novozymes has different divisions and offers solutions such as enzymes and microorganisms that can be used in the food and beverage industry, pulp and paper industry, bioenergy, biopharmaceuticals, and many other areas. With its commitment to sustainability and environmental protection, Novozymes contributes to shaping a better future. Novozymes A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novozymes A/S stock

FCF Conversion Rate (FCF/EBITDA) of Novozymes A/S is 215.86 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Novozymes A/S changed from 69.31 % to 215.86 %, representing a 211.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Novozymes A/S since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Novozymes A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Novozymes A/S

All Key Metrics — Novozymes A/S